| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5571479 | Primary Care Diabetes | 2017 | 11 Pages |
Abstract
We highlight the market uptake of antidiabetic drugs commercialized during the last decade; despite further exploration is needed to clarify the cost-benefit ratio of these new antidiabetic medicines.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
RocÃo López-Sepúlveda, MarÃa Ángeles GarcÃa Lirola, Esther EspÃnola GarcÃa, Jose MarÃa Jurado MartÃnez, Salvadora MartÃn Sances, Sonia Anaya Ordóñez, José Cabeza Barrera,